statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	759
RU - Federazione Russa	216
SG - Singapore	125
IE - Irlanda	112
GB - Regno Unito	77
CN - Cina	72
SE - Svezia	58
BR - Brasile	55
IT - Italia	51
VN - Vietnam	43
FR - Francia	40
DE - Germania	39
HK - Hong Kong	29
FI - Finlandia	27
UA - Ucraina	27
IN - India	26
ES - Italia	13
ZA - Sudafrica	13
CA - Canada	9
AR - Argentina	7
KR - Corea	6
NL - Olanda	6
MA - Marocco	5
IQ - Iraq	4
PL - Polonia	4
TR - Turchia	4
BD - Bangladesh	3
CZ - Repubblica Ceca	3
VE - Venezuela	3
AT - Austria	2
CI - Costa d'Avorio	2
CO - Colombia	2
EC - Ecuador	2
KE - Kenya	2
PT - Portogallo	2
SK - Slovacchia (Repubblica Slovacca)	2
BB - Barbados	1
BO - Bolivia	1
BY - Bielorussia	1
CL - Cile	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
EG - Egitto	1
GY - Guiana	1
ID - Indonesia	1
IL - Israele	1
IR - Iran	1
JP - Giappone	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
LU - Lussemburgo	1
MN - Mongolia	1
MT - Malta	1
MX - Messico	1
NP - Nepal	1
PY - Paraguay	1
RO - Romania	1
RS - Serbia	1
TH - Thailandia	1
UZ - Uzbekistan	1
Totale	1.874

Nome	#
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up	223
Prospective Validation of ATA and ETA Sonographic Pattern Risk of Thyroid Nodules Selected for FNAC	215
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up	205
Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma?	194
A case of papillary thyroid cancer without aggressive histological features with nodal metastases detected during follow-up in a younger patients	165
Stato nutrizionale e risposta al trattamento con inibitori tirosino-chinasici nel carcinoma tiroideo avanzato	155
Improvement of overall survival using TKIs as salvage therapy in advanced thyroid carcinoma: Real‐life data on a single center experience	151
Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels	139
A case of papillary thyroid cancer without aggressive histological features with nodal metastyases in an older patients	122
Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up	117
Thyroid cancer- A case-Based Approach	111
Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up	105
Totale	1.902

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	6	0	0	0	0	0	0	0	0	0	0	0	6
2021/2022	117	9	13	11	17	3	6	3	5	1	13	15	21
2022/2023	177	11	21	28	16	8	40	4	17	17	11	4	0
2023/2024	162	4	5	17	3	6	35	66	1	4	0	2	19
2024/2025	353	6	16	47	18	47	30	6	10	44	10	43	76
2025/2026	751	63	82	61	128	162	29	104	20	28	32	27	15
Totale													1.902